Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 22, 2006
Target validation in drug discovery
Robert A Blake
Journal of Biomolecular Screening
|
October 22, 2003
A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype
Deborah J Moshinsky, Lany Ruslim, Robert A Blake, et al.
Journal of Biomolecular Screening
|
May 14, 2004
An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation
Kaumudi M Bhawe, Robert A Blake, Douglas O Clary, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2003
Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase
Huiping Guan, A Douglas Laird, Robert A Blake, et al.
Journal of Medicinal Chemistry
|
May 1, 2020
Monomeric Targeted Protein Degraders
Emily J Hanan, Jun Liang, Xiaojing Wang, et al.
Nature Communications
|
January 25, 2020
Chaperone mediated detection of small molecule target binding in cells
Kelvin F Cho, Taylur P Ma, Christopher M Rose, et al.
Molecular Cancer Therapeutics
|
May 16, 2003
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells
A Douglas Laird, Guangmin Li, Katherine G Moss, et al.
ACS Medicinal Chemistry Letters
|
December 18, 2024
Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery
Yuebiao Zhou, Star L Garrigues, Elisia Villemure, et al.
Journal of Medicinal Chemistry
|
May 29, 2024
Potency-Enhanced Peptidomimetic VHL Ligands with Improved Oral Bioavailability
Hao Wu, Jeremy Murray, Noriko Ishisoko, et al.
Molecular Cancer Therapeutics
|
November 18, 2003
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
Xueyan Wang, Phuong Le, Congxin Liang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Methods in Molecular Biology (Clifton, N.J.)
|
September 22, 2006
Target validation in drug discovery
Robert A Blake
Journal of Biomolecular Screening
|
October 22, 2003
A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype
Deborah J Moshinsky, Lany Ruslim, Robert A Blake, et al.
Journal of Biomolecular Screening
|
May 14, 2004
An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation
Kaumudi M Bhawe, Robert A Blake, Douglas O Clary, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 20, 2003
Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase
Huiping Guan, A Douglas Laird, Robert A Blake, et al.
Journal of Medicinal Chemistry
|
May 1, 2020
Monomeric Targeted Protein Degraders
Emily J Hanan, Jun Liang, Xiaojing Wang, et al.
Nature Communications
|
January 25, 2020
Chaperone mediated detection of small molecule target binding in cells
Kelvin F Cho, Taylur P Ma, Christopher M Rose, et al.
Molecular Cancer Therapeutics
|
May 16, 2003
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells
A Douglas Laird, Guangmin Li, Katherine G Moss, et al.
ACS Medicinal Chemistry Letters
|
December 18, 2024
Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery
Yuebiao Zhou, Star L Garrigues, Elisia Villemure, et al.
Journal of Medicinal Chemistry
|
May 29, 2024
Potency-Enhanced Peptidomimetic VHL Ligands with Improved Oral Bioavailability
Hao Wu, Jeremy Murray, Noriko Ishisoko, et al.
Molecular Cancer Therapeutics
|
November 18, 2003
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
Xueyan Wang, Phuong Le, Congxin Liang, et al.
Page
of 4